Bank CEOs meet with Trump to discuss Fannie Mae and Freddie Mac - Bloomberg
SEATTLE—Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth recently sold a portion of her shares in the pet insurance company, according to a filing with the Securities and Exchange Commission. The transaction, executed on March 4, involved the sale of 2,294 shares at a price of $31.39 per share, totaling $72,008. The sale comes as Trupanion’s stock has experienced a challenging year, with shares down nearly 30% year-to-date, though InvestingPro analysis suggests the stock is currently undervalued.
Following this transaction, Tooth retains ownership of 118,784 shares in the company. The sale was carried out under a Rule 10b5-1 trading plan, which was adopted on November 29, 2024, to facilitate financial diversification. As a result, Tooth did not have discretion over the timing of the sale. InvestingPro data reveals the stock’s high volatility, with a beta of 1.7 and significant price movements in recent months - subscribers can access 10+ additional exclusive insights about TRUP’s market behavior.
Trupanion, headquartered in Seattle, provides medical insurance for cats and dogs, and its shares are traded on the NASDAQ under the ticker symbol TRUP. The company generated revenue of $1.29 billion in the last twelve months, showing strong growth of 16%, with analysts expecting profitability improvements in the coming year.
In other recent news, Trupanion, Inc. reported its fourth-quarter 2024 earnings, showcasing a revenue increase of 14% year over year, reaching $337.3 million, slightly surpassing the forecast of $335.46 million. However, the company’s earnings per share (EPS) came in at $0.04, missing the analyst projection of $0.07. Subscription revenue grew by 19% year over year, highlighting a strong performance in this segment. Despite these positive figures, the company faced challenges such as a slowdown in subscriber growth and retention rates, which were noted by analysts from Stifel and Piper Sandler. Both firms adjusted their price targets for Trupanion, with Stifel lowering it to $41 and maintaining a Hold rating, while Piper Sandler reduced it to $52 but kept an Overweight rating.
Trupanion’s adjusted operating income for the subscription business rose by 30% to $35.8 million, reflecting improved operational efficiency. However, the company wrote off approximately $5.3 million in goodwill related to acquisitions in Europe, specifically Smart Paws and PetExpert. Analysts expressed concerns over the company’s ability to add new subscribers, as the number of new subscribers declined by 10% year-over-year in the fourth quarter. The company’s 2025 guidance indicates slower-than-expected revenue growth due to recent rate increases affecting the pace of subscription growth. Despite these challenges, Trupanion remains focused on expanding its market presence, particularly in underpenetrated areas like Europe, and aims to improve its retention and conversion rates in 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.